Retatrutide is still investigational and not widely approved for clinical use, whereas Tirzepatide is already approved and more widely accessible
Consistency is critical
Improved patient experience and adherence tools: smarter injection devices, connected apps, and adherence support are being paired with therapies to improve long-term outcomes
Simply enter your HSA/FSA card information at checkout as you would any debit or credit card
Researchers are studying how this triple-receptor activity affects body weight, appetite, glucose regulation, and energy balance
For patients in Connecticut considering medical weight loss, GLP-1 therapy, peptide-based care, or body-composition-focused treatment, the more important question is not who is talking about retatrutide